Pittenger & Anderson Inc Dexcom Inc Transaction History

Pittenger & Anderson Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$114.22 - $140.1 $4,568 - $5,604	40 Added 1.42%	2,853 $395,000
Q4 2023 Feb 02, 2024	BUY	$75.49 - $124.16 $212,353 - $349,262	2,813 New	2,813 $349,000
Q1 2023 May 10, 2023	BUY	$104.0 - $122.92 $6,136 - $7,252	59 Added 96.72%	120 $13,000
Q3 2022 Nov 15, 2022	BUY	$76.35 - $94.18 $1,908 - $2,354	25 Added 69.44%	61 $5,000
Q2 2022 Jul 14, 2022	BUY	$67.99 - $132.89 $1,835 - $3,588	27 Added 300.0%	36 $3,000
Q3 2021 Nov 12, 2021	BUY	$106.71 - $143.18 $213 - $286	2 Added 28.57%	9 $5,000
Q1 2021 May 12, 2021	BUY	$84.79 - $104.74 $169 - $209	2 Added 40.0%	7 $3,000
Q3 2020 Nov 10, 2020	BUY	$95.51 - $112.95 $477 - $564	5 New	5 $2,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Pittenger & Anderson Inc, based on Form 13F filings with the SEC.

Stay updated on Pittenger & Anderson Inc with notifications on news.